Recent News for IDXG - Interpace Diagnostics Group, Inc.

Date Title
Jul 22 Interpace inks new agreement with SelectHealth
Jul 22 Interpace Announces New Agreement with SelectHealth
Jul 18 Interpace Diagnostics Partners With AI Specialist To Diagnose Thyroid Cancer
Jul 18 Interpace inks deal for diagnosis of thyroid cancer; shares up 11% premarket
Jul 18 Interpace Diagnostics Enters Agreement with Predictive Oncology to Enhance Diagnosis of Thyroid Cancer Via AI-Driven Analysis
Jul 16 Mid-Afternoon Market Update: Crude Oil Down 4%; Cancer Genetics Shares Spike Higher
Jul 16 Cancer Genetics Sharply Higher After Interpace Buys Biopharma Unit
Jul 16 A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Citigroup, Wells Fargo Earnings
Jul 16 11 Stocks To Watch For July 16, 2019
Jul 15 Interpace up 9% after hours on Cancer Genetics deal
Jul 15 Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
Jul 15 Those Who Purchased Interpace Diagnostics Group (NASDAQ:IDXG) Shares Five Years Ago Have A 98% Loss To Show For It
Jun 20 Health insurer to cover Interpace Diagnostics cancer tests
Jun 20 Interpace Diagnostics Announces Coverage of Molecular Thyroid Testing by Independence Blue Cross
Jun 13 Interpace Diagnostics Announces Presentation at the World Congress on Thyroid Cancer
May 14 Interpace Diagnostics Group, Inc. (IDXG) CEO Jack Stover on Q1 2019 Results - Earnings Call Transcript
May 14 Edited Transcript of IDXG earnings conference call or presentation 13-May-19 8:30pm GMT
May 13 Interpace Diagnostics misses by $0.04, misses on revenue
May 13 Interpace Q1 revenue up 25%
May 13 Interpace Diagnostics Reports First Quarter 2019 Financial Results and Provides Business Update
May 9 Interpace Diagnostics BarreGEN® Data to be Presented at Digestive Disease Week
May 6 Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results on Monday, May 13, 2019
May 1 Interpace Diagnostics Announces Publication of Important New Data on Thyroid Test Performance
Apr 29 Interpace Diagnostics Group, Inc.'s (NASDAQ:IDXG) Shift From Loss To Profit
Apr 25 Interpace Diagnostics Labs Receive College of American Pathology (CAP) Accreditation
Back to the Main IDXG Page...